Show last authors
1 {{box cssClass="floatinginfobox" title="**Contents**"}}
2 {{toc/}}
3 {{/box}}
4
5 = =
6
7 Invictus MD (IVITF) is a cannabis company founded in Vancouver, Canada. Invictus MD went public December 2014. The company represent a platform of licensed producers, under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), dedicated to providing high-quality, regulated pharma-grade cannabis for medical and recreational use. The company's growers are supported by over 250 acres of buildable property with full access to its team of industry-leading horticulturists, biochemists, and project managers.{{footnote}}https://fintel.io/doc/sec/1737647/000106299319000266/form40fr12b.htm{{/footnote}}
8
9 = Production update =
10
11 **Acreage Pharms Ltd - West-Central, Alberta**
12
13 **Phase 1 - Existing**
14
15 * 6,800 sq ft purpose built concrete and steel facility
16 * 609 kg cannabis cultivation capacity per annum
17 * Level 8 vault allows for storage onsite of $31.25MM of dried cannabis
18 * The current 150-acre property can accommodate future expansion plans
19 * Invictus MD owns 100% of Acreage Pharms
20
21 **Phase 2 - Funded Expansion**
22
23 * 32,000 sq ft purpose built concrete and steel facility
24 * 4,391 kg cannabis capacity per annum
25 * Purpose built concrete and steel facility
26 * Level 8 vault will allow for storage onsite of $31.25MM of product
27 * $6.0MM Project
28 * Permitted, construction in progress - expected completion by January 2018
29 * Fully funded
30
31 **Phase 3 - Expansion**
32
33 * 76,750 sq ft purpose built concrete and steel facility
34 * 9,000 kg cannabis cultivation capacity per annum
35 * $16.5MM Project expected to be completed by June 2018 - subject to permitting
36 * Fully funded
37
38 **AB Laboratories Inc. - Hamilton, Ontario**
39
40 * 16,000 sq ft purpose built concrete and steel facility
41 * 1,000 kg cannabis cultivation capacity per annum
42 * Actively seeking adjoining properties for direct expansion to the existing facility
43 * Invictus MD owns 33 1/3 of AB Laboratories Inc.
44
45 **Phase 1 - Funded Expansion**
46
47 * 21,000 sq ft expansion plan is expected to be completed by the end of 2017 with an additional 21,000 sq ft building envelope
48 * 3,000 kg cannabis cultivation capacity per annum
49 * Purpose built concrete and steel facility
50 * $5.5MM projected cost for Phase 1 expansion
51 * Fully funded subject to permitting
52
53 = Production Forecast =
54
55 |=Year|=Acreage Pharms (kg)|=AB Labs (kg)|=AB Ventures (kg)|=Total (kg)
56 |2017|50|250|0|300
57 |2018|3,850|1,000|3,000|7,850
58 |2019|8,000|1,000|8,000|17,000
59 |2020|15,000|1,000|15,000|31,000
60 |2021|25,000|1,000|24,000|50,000
61
62 = References =
63
64 {{putFootnotes/}}
This site is funded and maintained by Fintel.io